AI With Accountability: How Small Biopharma Can Scale Smarter - Syneos Health
High confidence: full text extraction produced 1813 characters.
AI With Accountability: How Small Biopharma Can Scale Smarter
In this episode, recorded on the ground at Asembia's AXS26 Summit, host Chris Van Denburg sits down with George Jones, Chief Commercial Officer at Biofrontera, to explore how artificial intelligence (AI) is helping smaller biopharmaceutical companies operate more efficiently while maintaining quality, oversight and accountability. George shares how Biofrontera is leveraging AI to streamline commercial operations, automate workflows and generate actionable insights that support smarter, faster decision-making.
The conversation explores practical applications of AI across commercial analytics, territory planning, reimbursement analysis and customer service, highlighting how lean organizations can create greater scale without adding headcount. George explains why AI should be viewed as an assistant that enhances human expertise rather than replaces it, enabling teams to focus on higher-value work while improving operational efficiency and patient access.
The episode also examines why responsible AI adoption requires strong governance. George discusses the importance of keeping a "human in the loop" to validate AI-generated insights, mitigate risks such as hallucinations and confirmation bias, and ensure technology supports sound business decisions that ultimately benefit healthcare providers and the patients they serve.
The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
Like what you’re hearing? Find the full Conversations on Commercialization podcast stream here. Also available anywhere you listen to podcasts.
Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].